{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T12:23:28Z","timestamp":1774959808583,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T00:00:00Z","timestamp":1507766400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s00259-017-3840-z","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T12:01:55Z","timestamp":1507809715000},"page":"2249-2256","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Multimodal correlation of dynamic [18F]-AV-1451 perfusion PET and neuronal hypometabolism in [18F]-FDG PET"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2850-9450","authenticated-orcid":false,"given":"Jochen","family":"Hammes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Leuwer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9rard N.","family":"Bischof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Drzezga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thilo","family":"van Eimeren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,12]]},"reference":[{"key":"3840_CR1","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/acn3.339","volume":"3","author":"GN Bischof","year":"2016","unstructured":"Bischof GN, Jessen F, Fliessbach K, et al. Impact of tau and amyloid burden on glucose metabolism in Alzheimer\u2019s disease. Ann Clin Transl Neurol. 2016;3:934\u20139.","journal-title":"Ann Clin Transl Neurol"},{"key":"3840_CR2","unstructured":"Dronse J, Fliessbach K, Bischof GN, et al. In vivo Patterns of Tau Pathology, Amyloid-\u03b2 Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer\u2019s Disease. J Alzheimers Dis. 2016:1\u20137."},{"key":"3840_CR3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ana.24546","volume":"79","author":"KA Johnson","year":"2016","unstructured":"Johnson KA, Schultz A, Betensky RA, et al. Tau positron emission tomographic imaging in aging and early Alzheimer disease. Ann Neurol. 2016;79:110\u20139.","journal-title":"Ann Neurol"},{"key":"3840_CR4","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1212\/WNL.0000000000003636","volume":"88","author":"S Spina","year":"2017","unstructured":"Spina S, Schonhaut DR, Boeve BF, et al. Frontotemporal dementia with the V337M MAPT mutation: Tau-PET and pathology correlations. Neurology. 2017;88:758\u201366.","journal-title":"Neurology"},{"key":"3840_CR5","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s00259-015-3231-2","volume":"43","author":"M Dani","year":"2016","unstructured":"Dani M, Brooks DJ, Edison P. Tau imaging in neurodegenerative diseases. Eur J Nucl Med Mol Imaging. 2016;43:1139\u201350.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3840_CR6","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/mds.26727","volume":"32","author":"J Hammes","year":"2017","unstructured":"Hammes J, Bischof GN, Giehl K, et al. Elevated in vivo [18F]-AV-1451 uptake in a patient with progressive supranuclear palsy. Mov Disord. 2017;32:170\u20131.","journal-title":"Mov Disord"},{"key":"3840_CR7","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/mds.26844","volume":"32","author":"H Cho","year":"2017","unstructured":"Cho H, Choi JY, Hwang MS, et al. Subcortical (18) F-AV-1451 binding patterns in progressive supranuclear palsy. Mov Disord. 2017;32:134\u201340.","journal-title":"Mov Disord"},{"key":"3840_CR8","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/mds.26834","volume":"32","author":"JL Whitwell","year":"2017","unstructured":"Whitwell JL, Lowe VJ, Tosakulwong N, et al. [18F]AV-1451 tau positron emission tomography in progressive supranuclear palsy. Mov Disord. 2017;32:124\u201333.","journal-title":"Mov Disord"},{"key":"3840_CR9","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/mds.26813","volume":"32","author":"R Smith","year":"2017","unstructured":"Smith R, Schain M, Nilsson C, et al. Increased basal ganglia binding of (18) F-AV-1451 in patients with progressive supranuclear palsy. Mov Disord. 2017;32:108\u201314.","journal-title":"Mov Disord"},{"key":"3840_CR10","doi-asserted-by":"crossref","first-page":"996","DOI":"10.2967\/jnumed.116.182980","volume":"58","author":"T Betthauser","year":"2017","unstructured":"Betthauser T, Lao PJ, Murali D, et al. In vivo comparison of tau radioligands 18F-THK-5351 and 18F-THK-5317. J Nucl Med. 2017;58:996\u20131002.","journal-title":"J Nucl Med"},{"key":"3840_CR11","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jalz.2012.11.008","volume":"9","author":"C-F Xia","year":"2013","unstructured":"Xia C-F, Arteaga J, Chen G, et al. [18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer\u2019s disease. Alzheimers Dement. 2013;9:666\u201376.","journal-title":"Alzheimers Dement"},{"key":"3840_CR12","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1021\/acs.jmedchem.6b00166","volume":"59","author":"AM Walji","year":"2016","unstructured":"Walji AM, Hostetler ED, Selnick H, et al. Discovery of 6-(Fluoro-(18)F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine ([(18)F]-MK-6240): A positron emission tomography (PET) imaging agent for quantification of neurofibrillary tangles (NFTs). J Med Chem. 2016;59:4778\u201389.","journal-title":"J Med Chem"},{"key":"3840_CR13","doi-asserted-by":"publisher","unstructured":"van Eimeren T, Bischof GN, Drzezga AE. Is tau imaging more than just \u2018upside-down\u2019 FDG imaging? J Nucl Med; Epub ahead of print 10 May 2017. https:\/\/doi.org\/10.2967\/jnumed.117.190082 .","DOI":"10.2967\/jnumed.117.190082"},{"key":"3840_CR14","doi-asserted-by":"publisher","unstructured":"Ng KP, Pascoal TA, Mathotaarachchi S, et al. Monoamine oxidase B inhibitor, selegiline, reduces 18F\u2013THK5351 uptake in the human brain. Alzheimers Res Ther; 9. Epub ahead of print 31 March 2017. https:\/\/doi.org\/10.1186\/s13195-017-0253-y .","DOI":"10.1186\/s13195-017-0253-y"},{"key":"3840_CR15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13024-017-0162-3","volume":"12","author":"L Saint-Aubert","year":"2017","unstructured":"Saint-Aubert L, Lemoine L, Chiotis K, et al. Tau PET imaging: present and future directions. Mol Neurodegener. 2017;12:19.","journal-title":"Mol Neurodegener"},{"key":"3840_CR16","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S1474-4422(15)00093-9","volume":"14","author":"S Teipel","year":"2015","unstructured":"Teipel S, Drzezga A, Grothe MJ, et al. Multimodal imaging in Alzheimer\u2019s disease: validity and usefulness for early detection. Lancet Neurol. 2015;14:1037\u201353.","journal-title":"Lancet Neurol"},{"key":"3840_CR17","first-page":"37","volume":"4","author":"WD Heiss","year":"1984","unstructured":"Heiss WD, Herholz K, Pawlik G, et al. Positron emission tomography as a quantitative imaging method for demonstrating regional brain metabolism. Digitale Bilddiagn. 1984;4:37\u201345.","journal-title":"Digitale Bilddiagn"},{"key":"3840_CR18","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1177\/0271678X15617954","volume":"36","author":"AA Phillips","year":"2016","unstructured":"Phillips AA, Chan FH, Zheng MMZ, et al. Neurovascular coupling in humans: Physiology, methodological advances and clinical implications. J Cereb Blood Flow Metab. 2016;36:647\u201364.","journal-title":"J Cereb Blood Flow Metab"},{"key":"3840_CR19","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1007\/BF00181059","volume":"21","author":"R Mielke","year":"1994","unstructured":"Mielke R, Pietrzyk U, Jacobs A, et al. HMPAO SPET and FDG PET in Alzheimer\u2019s disease and vascular dementia: comparison of perfusion and metabolic pattern. Eur J Nucl Med. 1994;21:1052\u201360.","journal-title":"Eur J Nucl Med"},{"key":"3840_CR20","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1007\/s00259-016-3353-1","volume":"43","author":"S Tiepolt","year":"2016","unstructured":"Tiepolt S, Hesse S, Patt M, et al. Early [18F]florbetaben and [11C]PiB PET images are a surrogate biomarker of neuronal injury in Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging. 2016;43:1700\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3840_CR21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2967\/jnumed.110.082057","volume":"52","author":"AH Rostomian","year":"2011","unstructured":"Rostomian AH, Madison C, Rabinovici GD, et al. Early 11C-PIB frames and 18F-FDG PET measures are comparable: A study validated in a cohort of AD and FTLD patients. J Nucl Med. 2011;52:173\u20139.","journal-title":"J Nucl Med"},{"key":"3840_CR22","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2967\/jnumed.110.083683","volume":"52","author":"PT Meyer","year":"2011","unstructured":"Meyer PT, Hellwig S, Amtage F, et al. Dual-biomarker imaging of regional cerebral amyloid load and neuronal activity in dementia with PET and 11C-labeled Pittsburgh compound B. J Nucl Med. 2011;52:393\u2013400.","journal-title":"J Nucl Med"},{"key":"3840_CR23","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1007\/s00259-016-3359-8","volume":"43","author":"K-J Lin","year":"2016","unstructured":"Lin K-J, Hsiao I-T, Hsu J-L, et al. Imaging characteristic of dual-phase 18F-florbetapir (AV-45\/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer\u2019s disease and mild cognitive impairment. Eur J Nucl Med Mol Imaging. 2016;43:1304\u201314.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3840_CR24","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00259-011-2051-2","volume":"39","author":"I-T Hsiao","year":"2012","unstructured":"Hsiao I-T, Huang C-C, Hsieh C-J, et al. Correlation of early-phase 18F-florbetapir (AV-45\/Amyvid) PET images to FDG images: preliminary studies. Eur J Nucl Med Mol Imaging. 2012;39:613\u201320.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3840_CR25","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1097\/RLU.0000000000001474","volume":"42","author":"S Jin","year":"2017","unstructured":"Jin S, Oh M, Oh SJ, et al. Additional value of early-phase 18F-FP-CIT PET image for differential diagnosis of atypical parkinsonism. Clin Nucl Med. 2017;42:e80\u20137.","journal-title":"Clin Nucl Med"},{"key":"3840_CR26","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1007\/s00330-015-3696-1","volume":"25","author":"SCJ Verfaillie","year":"2015","unstructured":"Verfaillie SCJ, Adriaanse SM, Binnewijzend MAA, et al. Cerebral perfusion and glucose metabolism in Alzheimer\u2019s disease and frontotemporal dementia: two sides of the same coin? Eur Radiol. 2015;25:3050\u20139.","journal-title":"Eur Radiol"},{"key":"3840_CR27","doi-asserted-by":"crossref","unstructured":"Rodriguez-Vieitez E, Leuzy A, Chiotis K, et al. Comparability of [18F]THK5317 and [11C]PIB blood flow proxy images with [18F]FDG positron emission tomography in Alzheimer\u2019s disease. J Cereb Blood Flow Metab. 2016; 0271678X16645593","DOI":"10.1177\/0271678X16645593"},{"key":"3840_CR28","doi-asserted-by":"crossref","unstructured":"Evans AC, Collins DL, Mills SR, et al. 3D statistical neuroanatomical models from 305 MRI volumes. In: Nuclear Science Symposium and Medical Imaging Conference, 1993., 1993 I.E. Conference Record. 1993, pp. 1813\u20131817 vol.3.","DOI":"10.1109\/NSSMIC.1993.373602"},{"key":"3840_CR29","first-page":"507","volume":"10","author":"RA Fisher","year":"1915","unstructured":"Fisher RA. Frequency distribution of the values of the correlation coefficient in samples from an indefinitely large population. Biometrika. 1915;10:507\u201321.","journal-title":"Biometrika"},{"key":"3840_CR30","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/hbm.10123","volume":"19","author":"A Hammers","year":"2003","unstructured":"Hammers A, Allom R, Koepp MJ, et al. Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum Brain Mapp. 2003;19:224\u201347.","journal-title":"Hum Brain Mapp"},{"key":"3840_CR31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.schres.2005.11.020","volume":"83","author":"N Makris","year":"2006","unstructured":"Makris N, Goldstein JM, Kennedy D, et al. Decreased volume of left and total anterior insular lobule in schizophrenia. Schizophr Res. 2006;83:155\u201371.","journal-title":"Schizophr Res"},{"key":"3840_CR32","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/nimg.2001.0978","volume":"15","author":"N Tzourio-Mazoyer","year":"2002","unstructured":"Tzourio-Mazoyer N, Landeau B, Papathanassiou D, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage. 2002;15:273\u201389.","journal-title":"NeuroImage"},{"key":"3840_CR33","first-page":"1238","volume":"36","author":"S Minoshima","year":"1995","unstructured":"Minoshima S, Frey KA, Koeppe RA, et al. A diagnostic approach in Alzheimer\u2019s disease using three-dimensional stereotactic surface projections of Fluorine-18-FDG PET. J Nucl Med. 1995;36:1238\u201348.","journal-title":"J Nucl Med"},{"key":"3840_CR34","first-page":"115","volume-title":"Forschung und wissenschaftliches Rechnen 2003","author":"S Vollmar","year":"2004","unstructured":"Vollmar S, \u010c\u00ed\u017eek J, Su\u00e9 M, et al. VINCI-volume imaging in neurological research, co-registration and ROIs included. In: Kremer K, Macho V, editors. Forschung und wissenschaftliches Rechnen 2003. G\u00f6ttingen: GWDG; 2004. p. 115\u201331."},{"key":"3840_CR35","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2385-6-4","volume":"6","author":"CO Wong","year":"2006","unstructured":"Wong CO, Thie J, Gaskill M, et al. A statistical investigation of normal regional intra-subject heterogeneity of brain metabolism and perfusion by F-18 FDG and O-15 H2O PET imaging. BMC Nucl Med. 2006;6:4.","journal-title":"BMC Nucl Med"},{"key":"3840_CR36","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/brain\/aww027","volume":"139","author":"R Ossenkoppele","year":"2016","unstructured":"Ossenkoppele R, Schonhaut DR, Sch\u00f6ll M, et al. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer\u2019s disease. Brain. 2016;139:1551\u201367.","journal-title":"Brain"},{"key":"3840_CR37","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jalz.2016.06.1069","volume":"12","author":"DR Schonhaut","year":"2016","unstructured":"Schonhaut DR, Ossenkoppele R, Bejanin A, et al. Tau-pet patterns overlap and exceed hypometabolism in Alzheimer\u2019s disease. Alzheimers Dement. 2016;12:545\u2013P547.","journal-title":"Alzheimers Dement"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-017-3840-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-017-3840-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-017-3840-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T10:56:47Z","timestamp":1659610607000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-017-3840-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,12]]},"references-count":37,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["3840"],"URL":"https:\/\/doi.org\/10.1007\/s00259-017-3840-z","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,12]]}}}